Last reviewed · How we verify
NCT03109574: ADOPT
Access in Dialysis for Better Outcomes in Patient Therapy
NA trial testing BioFlo DuraMax Chronic Hemodialysis Catheter in Central Venous Catheter in 92 participants. Completed in 30 June 2019.
30 June 2019
Quick facts
| Lead sponsor | William Osler Health System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 92 |
| Start date | 29 August 2016 |
| Primary completion | 30 June 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 3 locations across Canada |
Drugs / interventions tested
- BioFlo DuraMax Chronic Hemodialysis Catheter
- Standard of Care Catheter
Conditions studied
- Central Venous Catheter — all drugs for Central Venous Catheter →
- Catheter-Related Bloodstream Infection (CRBSI) Nos — all drugs for Catheter-Related Bloodstream Infection (CRBSI) Nos →
Sponsor
William Osler Health System
Who can join
18 and older, any sex, with Central Venous Catheter or Catheter-Related Bloodstream Infection (CRBSI) Nos. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, multi-center health economic study in Canada. Participants will be randomly assigned to receive either the study or control dialysis catheter. The primary objective is to evaluate resource utilization in Ontario related to hemodialysis catheter placement including tissue plasminogen activator (tPA) usage, catheter exchange rates, catheter patency, and missed dialysis days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03109574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Central Venous Catheter
Currently open trials in the same condition.
- NCT07014722 — Contact Activation of Coagulation in Newly Inserted Central Venous Catheters · NA · recruiting
- NCT06451185 — Statseal® for Central Venous Catheter Insertion Sites in Critical Care · NA · active not recruiting
- NCT06657534 — SISIPUSH: Evaluation of Hemolysis and Iatrogenic Anemia Using the Push-pull Method to Obtain Blood from Pediatric Patien · NA · recruiting
Other William Osler Health System trials
Trials by the same sponsor.
- NCT05806255 — Implementation of RELIEF for Patients With Palliative Care Needs · NA · unknown
- NCT04706754 — Pan-Canadian Lung Cancer Observational Study (PALEOS) · recruiting
- NCT03265067 — Field Implementation of the autoRIC Device in STEMI · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03109574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by William Osler Health System
- Last refreshed: 5 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing